Literature DB >> 20832111

Phenotype and functional analysis of human monocytes-derived dendritic cells loaded with a carbosilane dendrimer.

Marjorie Pion1, Maria J Serramia, Laura Diaz, Maria Bryszewska, Teresa Gallart, Felipe García, Rafael Gómez, Francisco J de la Mata, Maria Á Muñoz-Fernandez.   

Abstract

Dendritic cells (DCs) play a major role in development of cell-mediated immunotherapy due to their unique role in linking innate and adaptive immunities. In spite of improvement in this area, strategies employing ex vivo generated DCs have shown limited efficacy in clinical trials. Dendrimers have been proposed as new carriers for drug delivery in aim to ameliorate DCs antigen loading that is a pivotal point in DCs approaches. In this study, we have investigated the phenotypic and functional characteristics of human monocytes-derived dendritic cells after HIV-derived peptides uptake in vitro. We have found that iDCs and mDCs were able to capture efficiently water soluble carbosilane (CBS) dendrimer 2 G-NN16 and did not induce changes in maturation markers levels at the DCs surface. Therefore, CBS 2 G-NN16-loaded mDCs migrated as efficiently as unloaded DCs towards CCL19 or CCL21. Furthermore, DCs viability, activation of allogenic naïve CD4 + T cells by mDCs and secretion of cytokines were not significantly changed by 2 G-NN16 loading. Summing up, our data indicate that CBS 2 G-NN16 has no negative effects on the pivotal properties of DCs in vitro. It should therefore be feasible to further develop this antigen loading strategy for clinical use in immunotherapy against viral infections.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20832111     DOI: 10.1016/j.biomaterials.2010.07.093

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

Review 1.  Dendritic cell based vaccines for HIV infection: the way ahead.

Authors:  Felipe García; Montserrat Plana; Nuria Climent; Agathe León; Jose M Gatell; Teresa Gallart
Journal:  Hum Vaccin Immunother       Date:  2013-08-02       Impact factor: 3.452

2.  Cellular vaccines in listeriosis: role of the Listeria antigen GAPDH.

Authors:  Ricardo Calderón-González; Elisabet Frande-Cabanes; Lucía Bronchalo-Vicente; M Jesús Lecea-Cuello; Eduardo Pareja; Alexandre Bosch-Martínez; Mónica L Fanarraga; Sonsoles Yañez-Díaz; Eugenio Carrasco-Marín; Carmen Alvarez-Domínguez
Journal:  Front Cell Infect Microbiol       Date:  2014-02-21       Impact factor: 5.293

3.  Nanotechnology as a New Therapeutic Approach to Prevent the HIV-Infection of Treg Cells.

Authors:  Didiana Jaramillo-Ruiz; Francisco Javier De La Mata; Rafael Gómez; Rafael Correa-Rocha; M Ángeles Muñoz-Fernández
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

4.  Identification and characterisation of T-cell epitopes for incorporation into dendritic cell-delivered Listeria vaccines.

Authors:  Ricardo Calderon-Gonzalez; Raquel Tobes; Eduardo Pareja; Elisabet Frande-Cabanes; Nikolai Petrovsky; Carmen Alvarez-Dominguez
Journal:  J Immunol Methods       Date:  2015-05-29       Impact factor: 2.303

Review 5.  Emergence of Nanotechnology to Fight HIV Sexual Transmission: The Trip of G2-S16 Polyanionic Carbosilane Dendrimer to Possible Pre-Clinical Trials.

Authors:  Ignacio Relaño-Rodríguez; Maria Ángeles Muñoz-Fernández
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

Review 6.  Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection.

Authors:  Chongbo Zhao; Zhujun Ao; Xiaojian Yao
Journal:  Vaccines (Basel)       Date:  2016-01-22

7.  Novel nanoparticle vaccines for Listeriosis.

Authors:  Ricardo Calderon-Gonzalez; Marco Marradi; Isabel Garcia; Nikolai Petrovsky; Carmen Alvarez-Dominguez
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

8.  Biomarker Tools to Design Clinical Vaccines Determined from a Study of Annual Listeriosis Incidence in Northern Spain.

Authors:  Ricardo Calderon-Gonzalez; Hector Teran-Navarro; José María Marimon; Claudia González-Rico; Jorge Calvo-Montes; Elisabet Frande-Cabanes; Miriam Alkorta-Gurrutxaga; M C Fariñas; Luis Martínez-Martínez; Emilio Perez-Trallero; Carmen Alvarez-Dominguez
Journal:  Front Immunol       Date:  2016-11-29       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.